Recent Updates
Recently added Catalysts
HCSG Positive Sentiment

Prime Healthcare Services, Inc. Schedules 2026 2nd Quarter Earnings Conference Call

Wednesday, July 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Prime Healthcare Services, Inc. has announced its earnings report for the second quarter of 2026, set to be released on August 12th. Following the report, a conference call will take place at 2:00 p.m. (ET) to discuss the results. Participants must pre-register to gain access to the call.
Price reaction · baseline $24.36 (2026-07-15 close) · hit after-hours · clean, no other HCSG news in the window
day 0 close · peak
+2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Prime Healthcare Services is actively engaging with stakeholders.
  • The scheduled earnings call indicates transparency in financial reporting.
  • Pre-registration allows for organized access to the call.

Full Press Release Details

ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare Services will report earnings the morning of August 12th, 2026, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results.Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. Access to the call will not be available to those who have not registered in advance.For those who are unable to listen t

Frequently Asked Questions

When will Prime Healthcare report its Q2 2026 earnings?

Prime Healthcare will report its Q2 2026 earnings on August 12th, 2026.

What time is the earnings conference call scheduled?

The earnings conference call is scheduled for 2:00 p.m. (ET).

How can I join the conference call?

Participants must pre-register by emailing EGarcia27@primehealthcare.com.

Is registration required to access the call?

Yes, pre-registration is required for access to the conference call.

ShareAdd on Google
Tags: HCSG Prime Healthcare earnings report conference call 2026
Last updated: Jul 15, 2026

Biotech snapshot

Cash runway
$165M liquidity · $0M/mo burn
Low dilution risk